Cobalt complexes modulate plasmid conjugation in Escherichia coli and Klebsiella pneumoniae

Ilyas Alav, Parisa Pordelkhaki, Pedro Ernesto de Resende, Hannah Partington, Simon Gibbons, Rianne M Lord, Michelle M C Buckner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Downloads (Pure)

Abstract

Antimicrobial resistance genes (ARG), such as extended-spectrum β-lactamase (ESBL) and carbapenemase genes, are commonly carried on plasmids. Plasmids can transmit between bacteria, disseminate globally, and cause clinically important resistance. Therefore, targeting plasmids could reduce ARG prevalence, and restore the efficacy of existing antibiotics. Cobalt complexes possess diverse biological activities, including antimicrobial and anticancer properties. However, their effect on plasmid conjugation has not been explored yet. Here, we assessed the effect of four previously characterised bis(N-picolinamido)cobalt(II) complexes lacking antibacterial activity on plasmid conjugation in Escherichia coli and Klebsiella pneumoniae. Antimicrobial susceptibility testing of these cobalt complexes confirmed the lack of antibacterial activity in E. coli and K. pneumoniae. Liquid broth and solid agar conjugation assays were used to screen the activity of the complexes on four archetypical plasmids in E. coli J53. The cobalt complexes significantly reduced the conjugation of RP4, R6K, and R388 plasmids, but not pKM101, on solid agar in E. coli J53. Owing to their promising activity, the impact of cobalt complexes was tested on the conjugation of fluorescently tagged extended-spectrum β-lactamase encoding pCTgfp plasmid in E. coli and carbapenemase encoding pKpQILgfp plasmid in K. pneumoniae, using flow cytometry. The complexes significantly reduced the conjugation of pKpQILgfp in K. pneumoniae but had no impact on pCTgfp conjugation in E. coli. The cobalt complexes did not have plasmid-curing activity, suggesting that they target conjugation rather than plasmid stability. To our knowledge, this is the first study to report reduced conjugation of clinically relevant plasmids with cobalt complexes. These cobalt complexes are not cytotoxic towards mammalian cells and are not antibacterial, therefore they could be optimised and employed as inhibitors of plasmid conjugation.

Original languageEnglish
Article number8103
Number of pages12
JournalScientific Reports
Volume14
Issue number1
DOIs
Publication statusPublished - 6 Apr 2024

Bibliographical note

I.A. and M.M.C.B. were funded by the MRC grant MR/V009885/1 (New Investigator Research Grant to M.M.C.B.). H.P. was funded by a Frank Kerr undergraduate research award. R.M.L. was funded by the University of East Anglia start-up and the UKRI FLF MR/T041315/1.

Keywords

  • Animals
  • Escherichia coli/genetics
  • Klebsiella pneumoniae/genetics
  • Agar/pharmacology
  • beta-Lactamases/genetics
  • Anti-Bacterial Agents/pharmacology
  • Plasmids/genetics
  • Anti-Infective Agents/pharmacology
  • Klebsiella Infections/microbiology
  • Microbial Sensitivity Tests
  • Mammals/genetics

Fingerprint

Dive into the research topics of 'Cobalt complexes modulate plasmid conjugation in Escherichia coli and Klebsiella pneumoniae'. Together they form a unique fingerprint.

Cite this